Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. (Q43627756)
Jump to navigation
Jump to search
scientific article published in June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. |
scientific article published in June 2001 |
Statements
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis (English)
O Sordet
C Rébé
I Leroy
J M Bruey
C Garrido
C Miguet
G Lizard
S Plenchette